Rocket Pharmaceuticals, Inc.
RCKT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001281895
In the last 90 days, Rocket Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 7 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $340.9M in total; Maverick Capital is the only superinvestor holding it.
Q2 2024 vs. Q1 2024
How the institutions holding Rocket Pharmaceuticals, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 185 | 1 | 178 | −6 |
| Shares | 92.4M | 89.3K | 91.2M | −1.02M (−1.1%) |
| Value | $2.48B | $2.41M | $1.96B | −$517.9M (−20.9%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Woodline Partners LP | 561,966 | $12.1M | 0.12% |
| EcoR1 Capital, LLC | 508,393 | $10.9M | 0.34% |
| Mirae Asset Global ETFs Holdings Ltd. | 198,771 | $4.28M | 0.01% |
| Jane Street Group, LLC | 130,538 | $2.81M | 0.00% |
| Millennium Management LLC | 105,325 | $2.27M | 0.00% |
| Renaissance Technologies LLC | 99,574 | $2.14M | 0.00% |
| Strategic Financial Concepts, LLC | 21,981 | $895.0K | 0.00% |
| Corebridge Financial, Inc. | 35,400 | $762.2K | 0.00% |
| Marshall Wace, LLP | 19,583 | $421.6K | 0.00% |
| Campbell & CO Investment Adviser LLC | 17,992 | $387.4K | 0.03% |
| Group One Trading, L.P. | 6,331 | $136.3K | 0.00% |
| Simplex Trading, LLC | 5,825 | $125.0K | 0.00% |
| Catalyst Funds Management Pty Ltd | 2,100 | $45.2K | 0.01% |
| Smartleaf Asset Management LLC | 383 | $8.21K | 0.00% |
| Jones Financial Companies LLLP | 220 | $4.74K | 0.00% |
| BFSG, LLC | 200 | $4.31K | 0.00% |
| Meeder Asset Management Inc | 178 | $3.83K | 0.00% |
| ADAR1 Capital Management, LLC | 100 | $2.15K | 0.00% |
| Innealta Capital, LLC | 49 | $1.05K | 0.00% |
| National Bank of Canada | 35 | $720 | 0.00% |
| Allspring Global Investments Holdings, LLC | 20 | $430 | 0.00% |
Sold out (27)
Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
Not filed for Q2 2024 yet (1)
Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Credit Suisse AG | 89,280 | $2.41M |